![Statistical design in phase II clinical trials and its application in breast cancer - The Lancet Oncology Statistical design in phase II clinical trials and its application in breast cancer - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2119431003/2093724774/gr1.jpg)
Statistical design in phase II clinical trials and its application in breast cancer - The Lancet Oncology
![Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies - Annals of Oncology Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/4fbd2c57-dfa8-4450-b959-3e2174f9ad57/gr1.jpg)
Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies - Annals of Oncology
![CONSORT diagram for both the phase II clinical trial and the biomarker... | Download Scientific Diagram CONSORT diagram for both the phase II clinical trial and the biomarker... | Download Scientific Diagram](https://www.researchgate.net/profile/Vicente-Alfaro/publication/327822923/figure/fig1/AS:674671380946944@1537865600201/CONSORT-diagram-for-both-the-phase-II-clinical-trial-and-the-biomarker-substudy-Per.png)
CONSORT diagram for both the phase II clinical trial and the biomarker... | Download Scientific Diagram
![Representative diagram for the results of phase I and phase II clinical... | Download Scientific Diagram Representative diagram for the results of phase I and phase II clinical... | Download Scientific Diagram](https://www.researchgate.net/publication/347884803/figure/fig1/AS:983546692915201@1611507213736/Representative-diagram-for-the-results-of-phase-I-and-phase-II-clinical-trials-of-the.png)